Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Expert Opinion on Investigational Drugs
|
May 27, 2014
Investigational therapies for the treatment of atherosclerosis
Gerald H Tomkin, Daphne Owens
Journal of Translational Internal Medicine
|
February 14, 2017
Obesity diabetes and the role of bile acids in metabolism
Gerald H Tomkin, Daphne Owens
World Journal of Diabetes
|
July 18, 2015
Dyslipidaemia of diabetes and the intestine
Gerald H Tomkin, Daphne Owens
International Journal of Vascular Medicine
|
October 19, 2011
The chylomicron: relationship to atherosclerosis
Gerald H Tomkin, Daphne Owens
Expert Opinion on Investigational Drugs
|
April 4, 2017
Investigational therapies for hypercholesterolemia
Gerald H Tomkin, Daphne Owens
Metabolism: Clinical and Experimental
|
February 13, 2007
Genes that affect cholesterol synthesis, cholesterol absorption, and chylomicron assembly: the relationship between the liver and intestine in control and streptozotosin diabetic rats
Sean Lally, Daphne Owens, Gerald H Tomkin
Atherosclerosis
|
June 9, 2005
Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes
Catherine Phillips, Daphne Owens, Patrick Collins, et al.
Atherosclerosis
|
September 27, 2005
Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition
Catherine Phillips, Karen Mullan, Daphne Owens, et al.
International Journal of Experimental Diabetes Research
|
December 3, 2002
Defective chylomicron synthesis as a cause of delayed particle clearance in diabetes?
Catherine Phillips, Claire Madigan, Daphne Owens, et al.
Metabolism: Clinical and Experimental
|
June 22, 2002
Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes
Catherine Phillips, Andrew Bennett, Kay Anderton, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Expert Opinion on Investigational Drugs
|
May 27, 2014
Investigational therapies for the treatment of atherosclerosis
Gerald H Tomkin, Daphne Owens
Journal of Translational Internal Medicine
|
February 14, 2017
Obesity diabetes and the role of bile acids in metabolism
Gerald H Tomkin, Daphne Owens
World Journal of Diabetes
|
July 18, 2015
Dyslipidaemia of diabetes and the intestine
Gerald H Tomkin, Daphne Owens
International Journal of Vascular Medicine
|
October 19, 2011
The chylomicron: relationship to atherosclerosis
Gerald H Tomkin, Daphne Owens
Expert Opinion on Investigational Drugs
|
April 4, 2017
Investigational therapies for hypercholesterolemia
Gerald H Tomkin, Daphne Owens
Metabolism: Clinical and Experimental
|
February 13, 2007
Genes that affect cholesterol synthesis, cholesterol absorption, and chylomicron assembly: the relationship between the liver and intestine in control and streptozotosin diabetic rats
Sean Lally, Daphne Owens, Gerald H Tomkin
Atherosclerosis
|
June 9, 2005
Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes
Catherine Phillips, Daphne Owens, Patrick Collins, et al.
Atherosclerosis
|
September 27, 2005
Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition
Catherine Phillips, Karen Mullan, Daphne Owens, et al.
International Journal of Experimental Diabetes Research
|
December 3, 2002
Defective chylomicron synthesis as a cause of delayed particle clearance in diabetes?
Catherine Phillips, Claire Madigan, Daphne Owens, et al.
Metabolism: Clinical and Experimental
|
June 22, 2002
Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes
Catherine Phillips, Andrew Bennett, Kay Anderton, et al.
Page
of 2